GASTRIC (STOMACH) CANCER

This study is testing whether a new cell therapy called RAK, made from umbilical cord blood, can help control advanced stomach cancer that has stopped responding to standard treatments. Researchers will compare the therapy against a control group in 90 patients to see if it exten…

This study is testing a new three-drug combination for people with advanced stomach or gastroesophageal cancer that has a specific marker called HER2-positive. The main goals are to find the safest and most effective dose of the new drug fruquintinib when added to two standard ca…

This study is testing a new drug, TCC1727, combined with other cancer medications for people with advanced solid tumors that have stopped responding to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will see how w…

This study is testing a new screening method to find stomach cancer early. About 15,000 adults aged 40 and older will take a stool DNA test and answer a health questionnaire. People with a positive result from either method will get a follow-up endoscopy to check for cancer.

This study is testing whether a drug called riluzole can help prevent the memory and thinking problems often called 'chemo brain' in people receiving chemotherapy for various cancers. About 24 adult patients will be randomly assigned to receive either riluzole or a placebo pill w…

This study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…

This study aims to understand if people infected with certain high-risk types of H. pylori bacteria are more likely to develop stomach cancer or pre-cancerous changes. Researchers will follow 3,000 adults over 10 years, observing their health through check-ups but not giving any …

This study aims to understand stomach cancer in Algeria by collecting information from 1,000 patients. Researchers will look at patient backgrounds, how the cancer was found, what treatments were used, and how patients responded. The goal is to create a detailed picture of stomac…

This study aims to understand how genes and proteins contribute to the development of stomach and esophageal cancers. Researchers will analyze tissue samples from biopsies and blood samples from 100 participants who either have these cancers or are at high inherited risk. The goa…